Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTanfield Regulatory News (TAN)

Share Price Information for Tanfield (TAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.70
Bid: 3.72
Ask: 4.10
Change: 0.01 (0.26%)
Spread: 0.38 (10.215%)
Open: 3.70
High: 3.70
Low: 3.70
Prev. Close: 3.90
TAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Snorkel Investment & Legal Proceedings Update

10 May 2022 07:00

RNS Number : 8316K
Tanfield Group PLC
10 May 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain

 

 

Tanfield Group Plc

("Tanfield" or the "Company")

 

 

Snorkel Investment & Legal Proceedings Update

 

 

The Board of Tanfield (the "Board") is pleased to update the market on its investment in Snorkel International Holdings LLC ("Snorkel"), the aerial work platform business.

 

Investment Background

 

· Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme Manufacturing LLC ("Xtreme") (the "Contemplated Transaction"), a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

· The Snorkel investment is valued at £19.1m. The outcome of the US and UK Proceedings referenced below could have an impact on this valuation.

 

· On 22 October 2019, the Company announced that it had received a Summons and Complaint, filed in Nevada (the "US Proceedings") by subsidiaries of Xtreme, relating to the Contemplated Transaction.

 

· On 24 October 2019, the Company announced it had become necessary to issue and serve a claim in the English High Court against Ward Hadaway (the "UK Proceedings"), the solicitor acting for the Company at the time of the Contemplated Transaction, in order to fully protect the Company's rights pending the outcome of the US Proceedings. 

 

· On 26 February 2021, Ward Hadaway was granted permission to join Foulston Siefkin, Tanfield's US based law firm who were retained in 2013 to draft the documents governed by US law relating to the Contemplated Transaction, into the UK Proceedings. As a result, the Company amended its claim to include Foulston Siefkin as a second defendant.

 

 

Highlights

 

· In the final quarter of 2021, Snorkel continued to see a recovery following the impact of the global COVID-19 pandemic with sales of US$41.0m, compared to US$24.2m for the same period in 2020, an increase of 69.2%.

 

· The full year sales of Snorkel in 2021 were US$155.0m, compared to US$110.8m in 2020, an increase of 39.9%.

 

· Both the US and UK Proceedings are continuing. The US Proceedings trial window is currently scheduled to begin in February 2023, with the UK Proceedings trial set for November 2022.

 

 

Business Update

 

Tanfield is a 49% shareholder in the equity of Snorkel following the joint venture between the Company and Xtreme, a company owned by Don Ahern of Ahern Rentals Inc, relating to Snorkel, in October 2013.

 

Snorkel continues to recover from the impact of the global COVID-19 pandemic, which impacted its ability to operate as normal, and has seen sales for the fourth quarter of 2021 increase by 69.2% to US$41.0m as compared to sales in the fourth quarter of 2020 of US$24.2m. Sales for the full year of 2021 increased by 39.9% to US$155.0m as compared to US$110.8m in 2020.

 

Despite the increase in sales in the fourth quarter of 2021, the EBITDA loss for the period remained consistent at US$4.3m as compared to US$4.4m in the fourth quarter of 2020. The Board once again note that the gross profit margin has reduced yet further to around 1.5% for the fourth quarter of 2021, compared to 6.6% for the fourth quarter of 2020. Furthermore, the gross profit margin for the full year of 2021 has reduced to 5.4%, compared to 7.2% in 2020. The Board are unaware of the reason for the reduction and continue to believe that the gross profit margins generally do not appear to be in line with the industry averages. There is currently ongoing work to investigate this.

 

Below is a summary of the consolidated operating statements for the last 5 years:

 

US$000's

2021

2020

2019

2018

2017

 

Net sales

154,951

110,764

220,844

200,507

165,811

Cost of goods sold

146,651

102,783

195,437

175,684

144,828

Gross profit

8,301

7,981

25,408

24,823

20,982

Gross profit margin

5.4%

7.2%

11.5%

12.4%

12.7%

Selling, general, admin & currency costs

17,861

20,565

25,496

21,859

19,621

EBITDA

(9,560)

(12,584)

(89)

2,964

1,361

Depreciation & non-operating costs

2,448

2,240

2,456

3,364

2,360

Net loss

(12,008)

(14,824)

(2,544)

(400)

(999)

 

 

The Board is not able to determine when the market for Snorkel's equipment will return to previous levels. However, it views the ongoing recovery and increases to sales as a positive development and is not aware of any reason why this improving trend should not continue. The Board expects to receive the results for the first quarter of 2022 shortly and will provide a further update at that time.

 

 

US & UK Proceedings

 

Further to the update on 31 January 2022, there are still ongoing deficiencies in the documents produced by Snorkel / Xtreme in the US Proceedings which continue to cause delays. Despite the Board's best efforts to have Snorkel / Xtreme resolve these deficiencies, it nevertheless became necessary to move back the US Proceedings trial window once more until after the UK Proceedings trial in November 2022. The US Proceeding trial window is therefore currently scheduled to begin in February 2023.

 

On 31 January 2022, the Company announced that it had amended its claim in the UK Proceedings to include Foulston Siefkin as a second defendant. Following this amendment, further pleadings have been exchanged and the claim continues to progress towards trial in November 2022. One of the next stages before trial is the preparation of expert accountancy evidence which seeks to value the Snorkel division at the time of the Contemplated Transaction. The Company has recently, as part of its disclosure obligations, provided the defendants with an appraisal report of the tangible and intangible assets of Snorkel at the time of the Contemplated Transaction, prepared in 2014 by independent experts in the field for Xtreme, which the Board understand is the basis for the $45.5m net fair market value that Snorkel / Xtreme declared was contributed by Tanfield as part of the Contemplated Transaction. The Board therefore continues to believe that the value of the Snorkel division at the time of the Contemplated Transaction was substantial.

 

The Board believes that a positive outcome to either or both of the US and UK Proceedings is a reasonable expectation, and the Company will continue to vigorously defend and advance its position in both proceedings, whilst continuing to seek advice. 

 

 

Further updates will be provided to Shareholders as and when appropriate.

 

 

 

For further information:

 

Tanfield Group Plc 020 7220 1666

Daryn Robinson

 

WH Ireland Limited - Nominated Advisor / Broker

James Joyce / Megan Liddell 020 7220 1666

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSSMFIUEESESI
Date   Source Headline
25th Apr 20249:14 amRNSReplacement Final Results for year end 31 Dec 2023
25th Apr 20247:00 amRNSFinal Results for the year ended 31 Dec 2023
20th Nov 20231:01 pmRNSSnorkel Investment Update
17th Aug 20237:00 amRNSSnorkel Investment Update
24th Jul 20237:00 amRNSInterim Results for the six-months to 30 June 2023
2nd Jun 20237:00 amRNSResult of AGM
18th May 20237:00 amRNSSnorkel Investment Update
21st Apr 20237:00 amRNSFinal Results and Notice of AGM
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSSnorkel Investment Update
15th Nov 20229:54 amRNSSnorkel Investment Update
18th Oct 20224:40 pmRNSSecond Price Monitoring Extn
18th Oct 20224:35 pmRNSPrice Monitoring Extension
18th Oct 202210:48 amRNSSnorkel Investment & Legal Proceeding Update
14th Oct 20221:17 pmRNSSnorkel Investment & Legal Proceeding Update
9th Sep 20227:00 amRNSInterim Results for the six months to 30 June 2022
24th Aug 20227:00 amRNSSnorkel Investment & Loan Subscription Update
3rd Aug 20228:46 amRNSResult of AGM
19th Jul 20224:36 pmRNSPrice Monitoring Extension
30th Jun 20227:00 amRNSFinal Results and Notice of AGM
26th May 202211:44 amRNSSnorkel Investment Update
24th May 20227:00 amRNSLoan Note Instrument
12th May 20224:40 pmRNSSecond Price Monitoring Extn
12th May 20224:35 pmRNSPrice Monitoring Extension
10th May 20227:00 amRNSSnorkel Investment & Legal Proceedings Update
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 202212:56 pmRNSLoan Subscription Update
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
18th Feb 20224:35 pmRNSPrice Monitoring Extension
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:36 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSSnorkel Legal Proceedings Update
28th Jan 20224:41 pmRNSSecond Price Monitoring Extn
28th Jan 20224:36 pmRNSPrice Monitoring Extension
27th Jan 20224:37 pmRNSPrice Monitoring Extension
18th Jan 20224:41 pmRNSSecond Price Monitoring Extn
18th Jan 20224:35 pmRNSPrice Monitoring Extension
4th Jan 20224:41 pmRNSSecond Price Monitoring Extn
4th Jan 20224:36 pmRNSPrice Monitoring Extension
29th Dec 20214:41 pmRNSSecond Price Monitoring Extn
29th Dec 20214:35 pmRNSPrice Monitoring Extension
16th Dec 20214:42 pmRNSSecond Price Monitoring Extn
16th Dec 20214:36 pmRNSPrice Monitoring Extension
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
3rd Dec 20214:41 pmRNSSecond Price Monitoring Extn
3rd Dec 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20214:36 pmRNSPrice Monitoring Extension
22nd Nov 20214:35 pmRNSPrice Monitoring Extension
18th Nov 20217:00 amRNSSnorkel Investment Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.